Tag Archives: diabetes screening

Does being diagnosed with type 1 diabetes at age 6 carry the same long-term risks as being diagnosed at 16? Researchers have been asking that question for years. Increasingly, evidence suggests that age at type 1 diabetes onset may help explain differences in complication patterns later in life. However, age …

Diabetes is often diagnosed only after blood sugar levels have already risen above normal. However, what if the earliest warning signs appeared years before glucose levels changed? That question is driving exciting research into metabolomics, a rapidly growing field that analyzes tiny molecules produced during normal metabolism. Instead of focusing …

For many years, C-peptide testing was viewed as a simple tool to distinguish type 1 diabetes from type 2 diabetes. However, the story has changed. As researchers gain a better understanding of pancreatic beta-cell function, C-peptide testing in diabetes has become much more valuable than a diagnostic aid alone. Today, …

Imagine screening for diabetes as easily as breathing into a handheld device. That idea is rapidly moving from research laboratories toward clinical reality. Scientists are developing breath tests for diabetes that analyze tiny molecules in exhaled air to identify early metabolic changes long before traditional symptoms develop. Although blood glucose …

Population-based screening for type 1 diabetes is entering a new era. While autoantibody testing remains the gold standard for identifying individuals at high risk, researchers are increasingly investigating whether type 1 diabetes genetic screening could identify susceptible people even earlier. Advances in genomic science now make it possible to estimate …

Postpartum screening after gestational diabetes is one of the most important yet overlooked steps in preventing future type 2 diabetes. Although blood glucose levels often return to normal after delivery, the long-term metabolic risk does not disappear. In fact, up to half of individuals diagnosed with gestational diabetes mellitus (GDM) …

For decades, diagnosing diabetes has depended on blood tests performed during routine medical visits. However, what if your smartwatch could recognize early warning signs before glucose levels become high enough for a formal diagnosis? Researchers are now exploring wearable technologies for diabetes screening that continuously analyze physiologic data collected throughout …

As cancer treatment becomes increasingly sophisticated, clinicians are encountering a growing metabolic challenge. Cancer therapy–induced hyperglycemia has emerged as an important concern with the expanding use of immunotherapies and targeted therapies. In some patients, hyperglycemia develops gradually. In others, particularly those receiving immune checkpoint inhibitors, severe diabetes and diabetic ketoacidosis …

Sexual health remains one of the most overlooked aspects of diabetes management, despite its significant impact on quality of life. While clinicians routinely discuss glycemic control, cardiovascular risk, and medication adherence, conversations about sexual function are often avoided by both patients and healthcare providers. Yet sexual health concerns related to …

For many people living with diabetes, complications such as retinopathy, nephropathy, and neuropathy are well-recognized concerns. However, growing evidence suggests that hearing loss may deserve a place on that list as well. Researchers are increasingly examining whether hearing loss reflects the same vascular and neurologic damage that contributes to complications …